BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33710792)

  • 1. Consistency of the S5 DNA methylation classifier in formalin-fixed biopsies versus corresponding exfoliated cells for the detection of pre-cancerous cervical lesions.
    Reuter C; Preece M; Banwait R; Boer S; Cuzick J; Lorincz A; Nedjai B
    Cancer Med; 2021 Apr; 10(8):2668-2679. PubMed ID: 33710792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping.
    Hernández-López R; Lorincz AT; Torres-Ibarra L; Reuter C; Scibior-Bentkowska D; Warman R; Nedjai B; Mendiola-Pastrana I; León-Maldonado L; Rivera-Paredez B; Ramírez-Palacios P; Lazcano-Ponce E; Cuzick J; Salmerón J;
    Clin Epigenetics; 2019 Oct; 11(1):140. PubMed ID: 31606044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance evaluation of kits for bisulfite-conversion of DNA from tissues, cell lines, FFPE tissues, aspirates, lavages, effusions, plasma, serum, and urine.
    Holmes EE; Jung M; Meller S; Leisse A; Sailer V; Zech J; Mengdehl M; Garbe LA; Uhl B; Kristiansen G; Dietrich D
    PLoS One; 2014; 9(4):e93933. PubMed ID: 24699908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation testing with S5 for triage of high-risk HPV positive women.
    Adcock R; Nedjai B; Lorincz AT; Scibior-Bentkowska D; Banwait R; Torrez-Martinez N; Robertson M; Cuzick J; Wheeler CM;
    Int J Cancer; 2022 Oct; 151(7):993-1004. PubMed ID: 35477862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women.
    Vasiljević N; Scibior-Bentkowska D; Brentnall AR; Cuzick J; Lorincz AT
    Gynecol Oncol; 2014 Mar; 132(3):709-14. PubMed ID: 24508839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia.
    Mirabello L; Schiffman M; Ghosh A; Rodriguez AC; Vasiljevic N; Wentzensen N; Herrero R; Hildesheim A; Wacholder S; Scibior-Bentkowska D; Burk RD; Lorincz AT
    Int J Cancer; 2013 Mar; 132(6):1412-22. PubMed ID: 22847263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a methylation classifier for predicting pre-cancer lesion among women with abnormal results between HPV16/18 and cytology.
    Gu YY; Zhou GN; Wang Q; Ding JX; Hua KQ
    Clin Epigenetics; 2020 Apr; 12(1):57. PubMed ID: 32317020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Diagnostic Potential of EPB41L3 Methylation in Cervical Cancer and Precancerous Lesions: A Systematic Review and Meta-Analysis.
    Sha Y; Liu Y; Yang X; Wang J; Zhang R; Shen F
    Gynecol Obstet Invest; 2024; 89(1):1-10. PubMed ID: 38081153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of viral and host genes and severity of cervical lesions associated with human papillomavirus type 16.
    Louvanto K; Franco EL; Ramanakumar AV; Vasiljević N; Scibior-Bentkowska D; Koushik A; Cuzick J; Coutlée F; Lorincz AT;
    Int J Cancer; 2015 Mar; 136(6):E638-45. PubMed ID: 25203794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV33 DNA methylation measurement improves cervical pre-cancer risk estimation of an HPV16, HPV18, HPV31 and \textit{EPB41L3} methylation classifier.
    Brentnall AR; Vasiljevic N; Scibior-Bentkowska D; Cadman L; Austin J; Cuzick J; Lorincz AT
    Cancer Biomark; 2015; 15(5):669-75. PubMed ID: 26406956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a DNA methylation HPV triage classifier in a screening sample.
    Lorincz AT; Brentnall AR; Scibior-Bentkowska D; Reuter C; Banwait R; Cadman L; Austin J; Cuzick J; Vasiljević N
    Int J Cancer; 2016 Jun; 138(11):2745-51. PubMed ID: 26790008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
    Rogeri CD; Silveira HCS; Causin RL; Villa LL; Stein MD; de Carvalho AC; Arantes LMRB; Scapulatempo-Neto C; Possati-Resende JC; Antoniazzi M; Longatto-Filho A; Fregnani JHTG
    Gynecol Oncol; 2018 Sep; 150(3):545-551. PubMed ID: 29960712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3.
    Boers A; Wang R; van Leeuwen RW; Klip HG; de Bock GH; Hollema H; van Criekinge W; de Meyer T; Denil S; van der Zee AGJ; Schuuring E; Wisman GBA
    Clin Epigenetics; 2016; 8():29. PubMed ID: 26962367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation in Predicting Progression of Untreated High-grade Cervical Intraepithelial Neoplasia.
    Louvanto K; Aro K; Nedjai B; Bützow R; Jakobsson M; Kalliala I; Dillner J; Nieminen P; Lorincz A
    Clin Infect Dis; 2020 Jun; 70(12):2582-2590. PubMed ID: 31344234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation for cervical cancer screening: a training set in China.
    Kong L; Wang L; Wang Z; Xiao X; You Y; Wu H; Wu M; Liu P; Li L
    Clin Epigenetics; 2020 Jun; 12(1):91. PubMed ID: 32576279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Triage of Premalignant Lesions in Liquid-Based Cervical Cytology and Circulating Cell-Free DNA from Urine, Using a Panel of Methylated Human Papilloma Virus and Host Genes.
    Guerrero-Preston R; Valle BL; Jedlicka A; Turaga N; Folawiyo O; Pirini F; Lawson F; Vergura A; Noordhuis M; Dziedzic A; Pérez G; Renehan M; Guerrero-Diaz C; De Jesus Rodríguez E; Diaz-Montes T; Rodríguez Orengo J; Méndez K; Romaguera J; Trock BJ; Florea L; Sidransky D
    Cancer Prev Res (Phila); 2016 Dec; 9(12):915-924. PubMed ID: 27671338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes.
    Brentnall AR; Vasiljević N; Scibior-Bentkowska D; Cadman L; Austin J; Szarewski A; Cuzick J; Lorincz AT
    Int J Cancer; 2014 Sep; 135(6):1425-32. PubMed ID: 24535756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer.
    Clarke MA; Luhn P; Gage JC; Bodelon C; Dunn ST; Walker J; Zuna R; Hewitt S; Killian JK; Yan L; Miller A; Schiffman M; Wentzensen N
    Int J Cancer; 2017 Aug; 141(4):701-710. PubMed ID: 28500655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved results of LINE-1 methylation analysis in formalin-fixed, paraffin-embedded tissues with the application of a heating step during the DNA extraction process.
    Wen X; Jeong S; Kim Y; Bae JM; Cho NY; Kim JH; Kang GH
    Clin Epigenetics; 2017; 9():1. PubMed ID: 28149329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of DNA methylation-based biomarkers in the cervical cancer screening program of northern Portugal: A feasibility study.
    Salta S; Maia-Moço L; Estevão-Pereira H; Sequeira JP; Vieira R; Bartosch C; Petronilho S; Monteiro P; Sousa A; Baldaque I; Rodrigues J; Sousa H; Tavares F; Henrique R; Jerónimo C
    Int J Cancer; 2021 Dec; 149(11):1916-1925. PubMed ID: 34460099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.